Literature DB >> 29549981

Clinical behavior and management of three types of renal angiomyolipomas.

Kun-Han Lee1, Han-Yu Tsai2, Yu-Ting Kao3, Hsin-Chia Lin4, Yi-Chun Chou5, Shih-Huan Su6, Cheng-Keng Chuang7.   

Abstract

OBJECTIVES: To analyze and present the demography, clinical behavior, especially the risk factors of tumor hemorrhage and management of sporadic angiomyolipoma (SAML), tuberous sclerosis complex associated angiomyolipoma (TSCAML) and epithelioid angiomyolipoma (EAML) in our institution.
METHODS: A retrospective study of 587 patients who were diagnosed with renal angiomyolipoma in our institution between January 2000 and May 2015 was done. The AMLs were diagnosed by ultrasonography, CT, or MRI. EAML was confirmed by histopathology. Medical records and follow-up results were analyzed using the SPSS version 22 software.
RESULTS: Out of 587 cases of renal AMLs, 87.4% were SAMLs, 8.7% were TSCAMLs and 3.9% were EAMLs. Most of the AML patients were asymptomatic. The most common presenting symptoms included flank pain and abdominal pain. The median tumor size of SAML, TSCAML, EAML were 4.7, 2.7, 10.5 cm respectively. Approximately half of SAMLs were conservatively treated, almost all TSCAMLs were treated conservatively, while all EAMLs were surgically treated. The median tumor size of hemorrhagic SAML cases was 8 cm versus non-hemorrhagic cases of 4.1 cm. The optimal cut-off point on the ROC curve for predicting SAML tumor hemorrhage was 7.35 cm.
CONCLUSION: A larger tumor size, younger patient's age and higher BMI value correlated with a higher risk of tumor hemorrhage. For tumor sizes less than 7.35 cm, we recommend active surveillance or TAE for hemorrhage prevention. We also suggest that surgical management should be considered for patients with tumors larger than 7.35 cm, symptomatic and progressive AML, or suspicious EAML.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Angioembolization; Angiomyolipoma; Epithelioid; Hemorrhage; Nephrectomy; Renal; Tuberous sclerosis complex

Mesh:

Year:  2018        PMID: 29549981     DOI: 10.1016/j.jfma.2018.02.012

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  6 in total

1.  Is There a Higher Incidence of Sporadic Renal Angiomyolipoma in Childhood Cancer Survivors?

Authors:  Jarmila Kruseová; Barbora Gottfriedová; Andrea Zichová; Karel Švojgr; Petr Hošek; Aleš Lukš; Martin Kynčl; Tomáš Eckschlager
Journal:  Clin Epidemiol       Date:  2021-08-11       Impact factor: 4.790

Review 2.  Evidence-based protocol-led management of renal angiomyolipoma: A review of literature.

Authors:  Sophie Vaggers; Patrick Rice; Bhaskar K Somani; Rajan Veeratterapillay; Bhavan P Rai
Journal:  Turk J Urol       Date:  2020-09-21

3.  Partial nephrectomy can be a successful treatment option for renal epithelioid angiomyolipoma: a case report and literature review.

Authors:  Aurelija Liulytė; Algirdas Žalimas; Raimundas Meškauskas; Jurgita Ušinskienė; Feliksas Jankevičius
Journal:  Acta Med Litu       Date:  2020

Review 4.  New Trends and Evidence for the Management of Renal Angiomyolipoma: A Comprehensive Narrative Review of the Literature.

Authors:  Juan Camilo Álvarez Restrepo; David Andres Castañeda Millan; Carlos Andres Riveros Sabogal; Andres Felipe Puentes Bernal; Wilfredo Donoso Donoso
Journal:  J Kidney Cancer VHL       Date:  2022-01-21

Review 5.  Active Surveillance for Renal Angiomyolipoma Less Than 4 Centimeters: A Systematic Review of Cohort Studies.

Authors:  Mohamed Zeid; Hani Sayedin; Nauman Nabi; Mamoun Abdelrahman; Prem Thomas Jacob; Bassem Alhadi; Subhasis Giri
Journal:  Cureus       Date:  2022-02-28

Review 6.  Transarterial Embolization for Sporadic Renal Angiomyolipoma: Patient Selection and Technical Considerations for Optimal Therapeutic Outcomes.

Authors:  Yena Jung; Min Jeong Choi; Bong Man Kim; You Me Kim; Yumi Seo
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-12-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.